Clinical Trial Update: Maintenance Therapy With Toripalimab Combined With Capecitabine/Placebo for Recurrent and Metastatic Nasopharyngeal Carcinoma [Phase 3]

View source ↗

Summary

Phase 3 trial update on maintenance therapy combining toripalimab with capecitabine versus placebo for recurrent/metastatic nasopharyngeal carcinoma; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Toripalimab (Toripalimab)
• Xeloda (capecitabine)

Snippet

Sponsor: XIANG YANQUN | Conditions: Nasopharyngeal Carcinoma, Maintenance Therapy | Phase 3 | Status: ACTIVE_NOT_RECRUITING